Oxidants in Receptor Tyrosine Kinase Signal Transduction Pathways

Antioxidants and Redox Signaling

Volumn 5, Issue 6, 2003, Pages 781-788

  Aslan, Mutay ^a   Özben, Tomris ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; OXIDIZING AGENT; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

AEROBIC METABOLISM; ATMOSPHERE; HUMAN; MOLECULAR EVOLUTION; PHOTOSYNTHESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; GROWTH SUBSTANCES; HUMANS; HYDROGEN PEROXIDE; MODELS, BIOLOGICAL; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXYGEN; PLATELET-DERIVED GROWTH FACTOR; REACTIVE OXYGEN SPECIES; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SUPEROXIDES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 0344827268     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/152308603770380089     Document Type: Review

References (66)

1. Abedi H and Zachary I. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 272: 15442-15451, 1997.
2. Aikawa R, Komuro I, Yamazaki T, Zou Y, Kudoh S, Tanaka M, Shiojima I, Hiroi Y, and Yazaki Y. Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats. J Clin Invest 100: 1813-1821, 1997.
3. Aslan M and Freeman BA. Oxidases and oxygenases in regulation of vascular nitric oxide signaling and inflammatory responses. Immunol Res 26: 107-118, 2002.
4. Babior BM. NADPH oxidase: an update. Blood 93: 1464-1476, 1999.
5. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, and Rhee SG. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 272: 217-221, 1997.
6. Bae YS, Sung JY, Kim OS, Kim YJ, Hur KC, Kazlauskas A, and Rhee SG. Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem 275: 10527-10531, 2000.
7. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, and Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 28: 1176-1179, 1994.
8. Bayraktutan U, Draper N, Lang D, and Shah AM. Expression of functional neutrophil-type NADPH oxidase in cultured rat coronary microvascular endothelial cells. Cardiovasc Res 38: 256-262, 1998.
9. Beckman JS, Beckman TW, Chen J, Marshall PA, and Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87: 1620-1624, 1990.
10. Berry C, Touyz R, Dominiczak AF, Webb RC, and Johns DG. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol 281: H2337-H2365, 2001.
11. Bogdan S and Klambt C. Epidermal growth factor receptor signaling. Curr Biol 11: R292-R295, 2001.
12. Byrd VM, Ballard DW, Miller GG, and Thomas JW. Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor-bearing Jurkat T cells. J Immunol 162: 5853-5859, 1999.
13. 2 in rat heart endothelial cells. Free Radic Biol Med 25: 891-897, 1998.
14. Claesson-Welsh L. Mechanism of action of platelet-derived growth factor. Int J Biochem Cell Biol 28: 373-385, 1996.
15. Claesson-Welsh L, Eriksson A, Westermark B, and Heldin CH. cDNA cloning and expression of the human A-type platelet-derived growth factor (PDGF) receptor establishes structural similarity to the B-type PDGF receptor. Proc Natl Acad Sci U S A 86: 4917-4921, 1989
16. Doanes AM, Hegland DD, Sethi R, Kovesdi I, Bruder JT, and Finkel T. VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases. Biochem Biophys Res Commun 255: 545-548, 1999.
17. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, and Cheresh DA. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol Cell 4: 915-924, 1999.
18. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med 77: 527-543, 1999.
19. Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 237: 1-30, 1999.
20. Folkman J and Shing Y. Angiogenesis. J Biol Chem 267: 10931-10934, 1992.
21. Freeman BA and Crapo JD. Biology of disease: free radicals and tissue injury. Lab Invest 47: 412-426, 1982.
22. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, and Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273: 30336-30343, 1998.
23. Goldfarb M. Signaling by fibroblast growth factors: the inside story. Sci STKE 2001: PE37, 2001.
24. Griendling KK, Minieri CA, Ollerenshaw JD, and Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148, 1994.
25. Griendling KK and Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 91: 21-27, 2000.
26. Gronwald RG, Grant FJ, Haldeman BA, Hart CE, O'Hara PJ, Hagen FS, Ross R, Bowen-Pope DF, and Murray MJ. Cloning and expression of a cDNA coding for the human platelet-derived growth factor receptor: evidence for more than one receptor class. Proc Natl Acad Sci U S A 85: 3435-3439, 1988.
27. Guo D, Jia Q, Song HY, Warren RS, and Donner DB. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J Biol Chem 270: 6729-6733, 1995.
28. Harden TK. G protein-dependent regulation of phospholipase C by cell surface receptors. Am Rev Respir Dis 141(Suppl): S119-S122, 1990.
29. Hashimoto E, Ogita T, Nakaoka T, Matsuoka R, Takao A, and Kira Y. Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am J Physiol 267: H1948-H1954, 1994.
30. 2 and vanadate in vitro. Biochem Biophys Res Commun 188: 773-779, 1992.
31. Huang K, Andersson C, Roomans GM, Ito N, and Claesson-Welsh L. Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers. Int J Biochem Cell Biol 33: 315-324, 2001.
32. Ishida M, Marrero MB, Schieffer B, Ishida T, Bernstein KE, and Berk BC. Angiotensin II activates pp60c-src in vascular smooth muscle cells. Circ Res 77: 1053-1059, 1995.
33. Ishida M, Ishida T, Thomas SM, and Berk BC. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res 82: 7-12, 1998.
34. Johnson DE and Williams LT. Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60: 1-41, 1993.
35. Kyaw M, Yoshizumi M, Tsuchiya K, Kirima K, and Tamaki T. Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells. Hypertens Res 24: 251-261, 2001.
36. Laursen JB, Rajagopalan S, Galis Z, Tarpey M, Freeman BA, and Harrison DG. Role of superoxide in angiotensin II-induced but not catecholamine-induced hypertension. Circulation 95: 588-593, 1997.
37. Lo YY and Cruz TF. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos expression in chondrocytes. J Biol Chem 270: 11727-11730, 1995.
38. Marumo T, Schini-Kerth VB, Fisslthaler B, and Busse R. Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 96: 2361-2367, 1997.
39. Matsui T, Heidaran M, Miki T, Popescu N, La Rochelle W, Kraus M, Pierce J, and Aaronson S. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science 243: 800-804, 1989.
40. Matsumoto T and Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 2001: RE21, 2001.
41. McNeil PL, Muthukrishnan L, Warder E, and D'Amore PA. Growth factors are released by mechanically wounded endothelial cells. J Cell Biol 109: 811-822, 1989.
42. Meier B, Jesaitis AJ, Emmendorffer A, Roesler J, and Quinn MT. The cytochrome b-558 molecules involved in the fibroblast and polymorphonuclear leucocyte superoxide-generating NADPH oxidase systems are structurally and genetically distinct. Biochem J 289: 481-486, 1993.
43. Moncada S. Nitric oxide. J Hypertens Suppl 12: S35-S39, 1994.
44. Morishita R, Gibbons GH, Ellison KE, Lee W, Zhang L, Yu H, Kaneda Y, Ogihara T, and Dzau VJ. Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme. J Clin Invest 94: 978-984, 1994.
45. Nose K, Shibanuma M, Kikuchi K, Kageyama H, Sakiyama S, and Kuroki T. Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur J Biochem 201: 99-106, 1991.
46. Pagano PJ, Clark JK, Cifuentes-Pagano ME, Clark SM, Callis GM, and Quinn MT. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc Natl Acad Sci U S A 94: 14483-14488, 1997.
47. Page K, Li J, Hodge JA, Liu PT, Vanden Hoek TL, Becker LB, Pestell RG, Rosner MR, and Hershenson MB. Characterization of a Racl signaling pathway to cyclin D(1) expression in airway smooth muscle cells. J Biol Chem 274: 22065-22071, 1999.
48. Patterson C, Ruef J, Madamanchi NR, Barry-Lane P, Hu Z, Horaist C, Ballinger CA, Brasier AR, Bode C, and Runge MS. Stimulation of a vascular smooth muscle cell NAD(P)H oxidase by thrombin. Evidence that p47(phox) may participate in forming this oxidase in vitro and in vivo. J Biol Chem 274: 19814-19822, 1999.
49. Powers CJ, McLeskey SW, and Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7: 165-197, 2000.
50. Rousseau S, Houle F, Landry J, and Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15: 2169-2177, 1997.
51. Rubbo H, Darley-Usmar V, and Freeman BA. Nitric oxide regulation of tissue free radical injury. Chem Res Toxicol 9: 809-820, 1996.
52. Schreck R, Rieber P, and Baeuerle PA. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10: 2247-2258, 1991.
53. Shibuya M, Ito N, and Claesson-Welsh L. Structure and function of vascular endothelial growth factor receptor-1 and -2. Curr Top Microbiol Immunol 237: 59-83, 1999.
54. Shima DT, Kuroki M, Deutsch U, Ng YS, Adamis AP, and D'Amore PA. The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J Biol Chem 271: 3877-3883, 1996.
55. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, and Lambeth JD. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401: 79-82, 1999.
56. Thannickal VJ, Day RM, Klinz SG, Bastien MC, Larios JM, and Fanburg BL. Ras-dependent and -independent regulation of reactive oxygen species by mitogenic growth factors and TGF-beta 1. FASEB J 14: 1741-1748, 2000.
57. Uings IJ, and Farrow SN. Cell receptors and cell signalling. Mol Pathol 53: 295-299, 2000.
58. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, and Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271: 23317-23321, 1996.
59. Ushio-Fukai M, Alexander RW, Akers M, and Griendling KK. p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273: 15022-15029, 1998.
60. Ushio-Fukai M, Griendling KK, Akers M, Lyons PR, and Alexander RW. Temporal dispersion of activation of phospholipase C-beta1 and -gamma isoforms by angiotensin II in vascular smooth muscle cells. Role of alphaq/11, alpha12, and beta gamma G protein subunits. J Biol Chem 273: 19772-19777, 1998.
61. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, and Alexander RW. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21: 489-495, 2001.
62. Viedt C, Soto U, Krieger-Brauer HI, Fei J, Elsing C, Kubler W, and Kreuzer J. Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol 20: 940-948, 2000.
63. Werner S, Roth WK, Bates B, Goldfarb M, and Hofschneider PH. Fibroblast growth factor 5 proto-oncogene is expressed in normal human fibroblasts and induced by serum growth factors. Oncogene 6: 2137-2144, 1991.
64. Wu LW, Mayo LD, Dunbar JD, Kessler KM, Baerwald MR, Jaffe EA, Wang D, Warren RS, and Donner DB. Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J Biol Chem 275: 5096-5103, 2000.
65. Xia P, Aiello LP, Ishii H, Jiang ZY, Park DJ, Robinson GS, Takagi H, Newsome WP, Jirousek MR, and King GL. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest 98: 2018-2026, 1996.
66. 2 in angiotensin II-induced vascular hypertrophy. Hypertension 32: 488-495, 1998.